Remove 2023 Remove Community Remove Consulting Remove Screening
article thumbnail

Access to health care and services for the Deaf: A scoping review of reviews [Health care services, delivery, and financing]

Annals of Family Medicine

A growing number of research has been published on the subject, but the Deaf community remains underserved in health care and under-represented in health research. A patient partner from the Deaf community collaborated on each step of this project. Results: Thirteen reviews published in English from 2010 to 2023 were included.

Finance 130
article thumbnail

Implementation and Uptake of the Virginia Mental Health Access Program [Child and adolescent health]

Annals of Family Medicine

Increasing access to primary care clinicians who are better able to screen and treat pediatric mental health conditions can improve mental health and reduce unnecessary ED visits. Analysis: This is a secondary analysis of clinician participation and uptake of consultation and training for pediatric mental health in Virginia between 2016-2023.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Psilocybin in Serious Illness: James Downar, Ali John Zarrabi and Margaret Ross

GeriPal

Summary Transcript CME Summary Weve covered psychedelics on the podcast beforefirst in 2019 with Ira Byock, where we explored their potential role in medicine , and then again in 2023 with Stacy Fischer, Brian Anderson, and Theora Cimino, focusing on the reasons to approach psychedelic use in patients with caution. Because we don’t.

Illness 107
article thumbnail

Caring for the Unrepresented: A Podcast with Joe Dixon, Timothy Farrell, Yael Zweig

GeriPal

Eric 13:00 I also love that too, because even on our inpatient ballot of care consult service, whenever somebody says that they’re unrepresented or they don’t have a surrogate, we never believe that until we usually look up. It’s been revised in 2023. Decision making hierarchies by default.

article thumbnail

Better Late Than Never – Unpacking FDA’s Highly Anticipated (and Long Overdue) Draft Guidance on Diversity Action Plans

FDA Law

The deadline for the Draft Guidance was December 29, 2023, so the draft, issued on June 26, 2024, is about 6 months late under FDORA’s mandate. FDA encourages sponsors to consult patients and healthcare providers to assist in developing such strategies. providing language assistance); Reducing participant burden (e.g.,

Clinic 59
article thumbnail

Telemedicine in a Post-Pandemic World: Joe Rotella, Brooke Calton, Carly Zapata

GeriPal

See the AAHPM Legislative Action Center [link] Write to the DEA, with guidance from AAHPM’s comments to the DEA March 2023. And I think that it was percolating in a lot of the palliative care community. Start with a story as Carly did in her Op Ed. Stories trump data. Write to your congressperson. Go ahead Eric. I’m sorry.